comparemela.com

Latest Breaking News On - Molecular therapeutics - Page 18 : comparemela.com

Allogene taps Arbor in pursuit of off-the-shelf CAR-T therapies for autoimmune disease

BioPharma

Feng zhangZachary robertsVertex pharmaceuticalsAllogene therapeuticsArbor biotechnologiesMarch ventureGinkgo bioworksMolecular therapeuticsGene therapy

Insider Selling: 4D Molecular Therapeutics, Inc (NASDAQ:FDMT) Insider Sells 1,909 Shares of Stock

4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) insider Scott Bizily sold 1,909 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $30.00, for a total value of $57,270.00. Following the sale, the insider now owns 1,737 shares in the company, valued at […]

Nova scotiaScott bizilyGoldman sachs group incRoyal bankVr adviserSecurities exchange commissionD molecular therapeutics incBlackrock incD molecular therapeutics company profileGoldman sachs groupMolecular therapeuticsGet free reportExchange commissionMolecular therapeutics stockStreet corpSachs group

4DMT Reports Full Year 2023 Financial Results and Operational Highlights

4DMT Reports Full Year 2023 Financial Results and Operational Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAstellas pharmaDavid kirnJulian peiKatherine smithD molecular therapeutics incCorporate communicationsExchange commissionFull yearDose expansionArbor biotechnologiesVector evolutionMolecular therapeuticsChief executive officerLarge market ophthalmologyWet age related macular degeneration

4D Molecular Therapeutics, Inc (FDMT) Reports FY Loss of $2 58

4D Molecular Therapeutics, Inc (FDMT) Reports FY Loss of $2 58
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

D molecular therapeutics incMolecular therapeutics

Dementia: Researchers link the stress response to brain cell death

New research suggests the body's inability to turn off the stress response is linked to brain cell death in neurodegenerative diseases like Alzheimer's and Parkinson's. Managing the stress response mechanism could pave the way for new treatment strategies for early-onset dementia.

David merrillAlpgiray kelem gettyK peter hirthSanta monicaPacific neuroscience institute brain health centerDivision of molecular therapeuticsMichael rapMolecular therapeuticsHirth chairCancer biologyMedical news todayPacific neuroscience institutePacific brain health centerStress response brain cell death alzheimers

vimarsana © 2020. All Rights Reserved.